SciELO - Scientific Electronic Library Online

 
vol.21 número1Efectividad del ultrasonido terapéutico en el tratamiento de la espasticidad del miembro superior pléjicoPropuesta de un plan de acción para reducir la mortalidad por cáncer de próstata en Holguín índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Correo Científico Médico

versão On-line ISSN 1560-4381

Resumo

REMEDIOS BATISTA, Susel Elisabet et al. Social Impact of a New Therapeutic Conduct for the Systemic Sclerosis. ccm [online]. 2017, vol.21, n.1, pp.219-235. ISSN 1560-4381.

A review was made on systemic sclerosis with a social philosophical focus of a critical and interdisciplinary nature, following research logic. In the scientific order a different and possibly more effective therapeutic behavior from the early stages is obtained, based on the clinical stage and specific organ commitment. Regarding   social approach it avoids complications and death, in the economic one it represents an advantage for the patient and relatives,   minimizing costs of diagnostic means resources; another applied therapy constitutes hospital stays; in the scientific community it is a working tool for the specialized care of scleroderma patients. The authors concluded that a concrete theoretical support on the advantages of therapeutics, generates new scientific knowledge for its practical validation, interdisciplinary branches of scientific knowledge with current historical approach achieve a comprehensive social vision of a problem of science and technology for sustainable solutions.

Palavras-chave : systemic sclerosis; cyclophosphamide; science technology society.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons